Anton F. H. Stalenhoef

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Marina Cuchel, Éric Bruckert, Henry N. Ginsberg et al. · European Heart Journal · 2014 · 1K citations · Full text

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.

Jacqueline de Graaf, Heidi L.M. Hak-Lemmers, M.P.C. Hectors et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1991 · 718 citations

Healthy Subjects, Lipid Peroxidation, Enhanced Susceptibility +22

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

Philip J. Barter, Christie M. Ballantyne, Rafael Carmena et al. · Journal of Internal Medicine · 2006 · 470 citations · Full text

Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans

Greetje J. de Grooth, Jan Albert Kuivenhoven, Anton F. H. Stalenhoef et al. · Circulation · 2002 · 451 citations · Full text

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome

Barbara Sjouke, D. Meeike Kusters, Iris Kindt et al. · European Heart Journal · 2014 · 434 citations · Full text